Creative Planning’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $25M | Buy |
397,852
+79,480
| +25% | +$6.36M | 0.02% | 357 |
|
|
2025
Q4 | $30.4M | Sell |
318,372
-11,112
| -3% | -$1.09M | 0.02% | 290 |
|
|
2025
Q3 | $32.2M | Buy |
329,484
+55,800
| +20% | +$5.78M | 0.02% | 261 |
|
|
2025
Q2 | $29.4M | Buy |
273,684
+15,673
| +6% | +$1.59M | 0.03% | 254 |
|
|
2025
Q1 | $26M | Buy |
258,011
+37,383
| +17% | +$3.76M | 0.02% | 264 |
|
|
2024
Q4 | $19.7M | Buy |
220,628
+16,420
| +8% | +$1.45M | 0.02% | 301 |
|
|
2024
Q3 | $17.1M | Buy |
204,208
+14,663
| +8% | +$1.16M | 0.02% | 311 |
|
|
2024
Q2 | $14.6M | Buy |
189,545
+22,901
| +14% | +$1.68M | 0.02% | 322 |
|
|
2024
Q1 | $11.4M | Buy |
166,644
+15,113
| +10% | +$972K | 0.01% | 376 |
|
|
2023
Q4 | $8.76M | Sell |
151,531
-3,571
| -2% | -$191K | 0.02% | 410 |
|
|
2023
Q3 | $8.19M | Sell |
155,102
-1,699
| -1% | -$89.1K | 0.01% | 404 |
|
|
2023
Q2 | $8.48M | Buy |
156,801
+15,406
| +11% | +$805K | 0.01% | 384 |
|
|
2023
Q1 | $7.07M | Buy |
141,395
+4,052
| +3% | +$191K | 0.01% | 410 |
|
|
2022
Q4 | $6.35M | Buy |
137,343
+10,735
| +8% | +$465K | 0.01% | 428 |
|
|
2022
Q3 | $4.9M | Sell |
126,608
-29,196
| -19% | -$1.17M | 0.01% | 443 |
|
|
2022
Q2 | $5.81M | Buy |
155,804
+2,075
| +1% | +$84.5K | 0.01% | 419 |
|
|
2022
Q1 | $6.81M | Buy |
153,729
+74,812
| +95% | +$3.24M | 0.01% | 384 |
|
|
2021
Q4 | $3.35M | Buy |
78,917
+2,802
| +4% | +$118K | 0.01% | 530 |
|
|
2021
Q3 | $3.3M | Buy |
76,115
+5,294
| +7% | +$234K | 0.01% | 532 |
|
|
2021
Q2 | $3.03M | Sell |
70,821
-2,221
| -3% | -$93.4K | 0.01% | 542 |
|
|
2021
Q1 | $2.82M | Buy |
73,042
+7,888
| +12% | +$299K | 0.01% | 589 |
|
|
2020
Q4 | $2.34M | Sell |
65,154
-1,164
| -2% | -$42K | 0.01% | 607 |
|
|
2020
Q3 | $2.53M | Buy |
66,318
+4,127
| +7% | +$159K | 0.01% | 482 |
|
|
2020
Q2 | $2.18M | Sell |
62,191
-1,923
| -3% | -$69.3K | 0.01% | 470 |
|
|
2020
Q1 | $2.09M | Sell |
64,114
-1,751
| -3% | -$68.4K | 0.01% | 421 |
|
|
2019
Q4 | $2.98M | Buy |
65,865
+2,199
| +3% | +$92K | 0.01% | 397 |
|
|
2019
Q3 | $2.59M | Buy |
63,666
+1,296
| +2% | +$54.9K | 0.01% | 426 |
|
|
2019
Q2 | $2.68M | Buy |
62,370
+10,770
| +21% | +$414K | 0.01% | 415 |
|
|
2019
Q1 | $1.98M | Buy |
51,600
+1,048
| +2% | +$40K | 0.01% | 463 |
|
|
2018
Q4 | $1.79M | Buy |
50,552
+1,505
| +3% | +$54.6K | 0.01% | 447 |
|
|
2018
Q3 | $1.89M | Buy |
49,047
+50
| +0.1% | +$1.75K | 0.01% | 496 |
|
|
2018
Q2 | $1.6M | Buy |
48,997
+5,390
| +12% | +$163K | 0.01% | 534 |
|
|
2018
Q1 | $1.19M | Sell |
43,607
-1,535
| -3% | -$41.7K | ﹤0.01% | 647 |
|
|
2017
Q4 | $1.12M | Buy |
45,142
+1,146
| +3% | +$31.6K | ﹤0.01% | 678 |
|
|
2017
Q3 | $1.28M | Buy |
43,996
+1,456
| +3% | +$40.2K | 0.01% | 605 |
|
|
2017
Q2 | $1.18M | Buy |
42,540
+2,234
| +6% | +$59.3K | 0.01% | 613 |
|
|
2017
Q1 | $1M | Sell |
40,306
-759
| -2% | -$18.5K | 0.01% | 672 |
|
|
2016
Q4 | $888K | Buy |
41,065
+340
| +0.8% | +$7.42K | 0.01% | 675 |
|
|
2016
Q3 | $969K | Buy |
40,725
+17,444
| +75% | +$416K | 0.01% | 605 |
|
|
2016
Q2 | $544K | Sell |
23,281
-78
| -0.3% | -$1.69K | ﹤0.01% | 732 |
|
|
2016
Q1 | $439K | Sell |
23,359
-14,141
| -38% | -$248K | ﹤0.01% | 808 |
|
|
2015
Q4 | $692K | Buy |
37,500
+14,404
| +62% | +$258K | 0.01% | 622 |
|
|
2015
Q3 | $379K | Buy |
23,096
+1,998
| +9% | +$34.2K | ﹤0.01% | 858 |
|
|
2015
Q2 | $373K | Buy |
21,098
+3,605
| +21% | +$64.4K | ﹤0.01% | 741 |
|
|
2015
Q1 | $311K | Sell |
17,493
-2,488
| -12% | -$39.3K | ﹤0.01% | 973 |
|
|
2014
Q4 | $265K | Sell |
19,981
-11
| -0.1% | -$141 | ﹤0.01% | 993 |
|
|
2014
Q3 | $236K | Sell |
19,992
-585
| -3% | -$7.37K | ﹤0.01% | 978 |
|
|
2014
Q2 | $263K | Buy |
20,577
+7,903
| +62% | +$103K | ﹤0.01% | 902 |
|
|
2014
Q1 | $171K | Buy |
12,674
+1,934
| +18% | +$25.4K | ﹤0.01% | 1075 |
|
|
2013
Q4 | $129K | Sell |
10,740
-232
| -2% | -$2.74K | ﹤0.01% | 1061 |
|
|
2013
Q3 | $129K | Buy |
10,972
+320
| +3% | +$3.46K | ﹤0.01% | 967 |
|
|
2013
Q2 | $99K | Buy |
+10,652
| New | +$90.4K | ﹤0.01% | 995 |
|
Other funds holding BSX
VCM
VPM
Creative Planning's BSX Position: Q1 2026 in Review
Creative Planning increased its Boston Scientific (BSX) stake by 25% in Q1 2026, buying an estimated $6.36M and bringing the position to 397,852 shares worth $25M. The position accounts for 0.02% of the portfolio, ranked #357.
Creative Planning first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $32.2M in Q3 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Creative Planning held 397,852 shares of Boston Scientific worth $25M as of Q1 2026.
- Creative Planning bought 79,480 Boston Scientific shares in Q1 2026, an estimated $6.36M.
- Boston Scientific made up 0.02% of Creative Planning's portfolio in Q1 2026, its #357 holding.
- Creative Planning first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- Creative Planning's Boston Scientific position peaked at $32.2M in Q3 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.